Clinical Trials Directory

Trials / Sponsors / Principia Biopharma, a Sanofi Company

Principia Biopharma, a Sanofi Company

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedPhase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727)
Atopic Dermatitis
Phase 22021-08-13
CompletedFood Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants
Healthy Volunteers
Phase 12021-04-07
CompletedPharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian Subjects
Healthy Volunteers
Phase 12021-01-04
Active Not RecruitingStudy to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (
Immune Thrombocytopenia
Phase 32020-12-14
CompletedA Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of
Hepatic Function Abnormal, Healthy Volunteers
Phase 12020-11-02
CompletedOpen Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
Immunoglobulin G4 Related Disease
Phase 22020-08-22
TerminatedA Study of PRN1008 in Patients With Pemphigus
Pemphigus
Phase 32019-01-08
CompletedA Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia
Phase 22018-03-22
CompletedA Study of PRN1008 in Adult Patients With Pemphigus Vulgaris
Pemphigus Vulgaris
Phase 22016-01-22
TerminatedA Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastati
Solid Tumors, Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter
Phase 12015-10-28